GNTX

Gentex Corp · NASDAQ

$20.13USDCS band Mixed

↓ $0.51 (2.47%) Today

As of Oct 27, 1:07 PM ET · May be delayed

Sign up free to see this.

Daily prices
Mkt Cap
$4.2B
Volume
3.1M
52W High
$26.48
52W Low
$19.98
PE Ratio
10.5
Avg Vol
2.8M
As of 10/26/26
Div Yield
2.46%
Beta
0.68
As of 10/26/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about GNTX?

Latest news

News ›

Zacks Investment Research

Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?

Gentex (GNTX), an automotive supplier specializing in automatic-dimming rearview mirrors, has a strong track record of beating earnings estimates with an average surprise of 12.55% over the past two quarters. The company's positive Earnings ESP of +0.66% combined with its Zacks Rank #3 suggests another potential earnings beat is likely when the company reports on October 23, 2026.

Zacks Investment Research

Gentex (GNTX) Reports Next Week: Wall Street Expects Earnings Growth

Gentex (GNTX) is positioned as a likely earnings beat candidate for Q3 2026 with a positive Earnings ESP of +0.66% and Zacks Rank #3, supported by a history of beating estimates. The company expects EPS of $0.51 (up 10.9% YoY) and revenues of $669.17 million (up 2.1% YoY). In contrast, peer Visteon (VC) faces challenges with a negative Earnings ESP of -4.05% and Zacks Rank #4, making an earnings beat unlikely despite modest revenue growth expectations.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Cylvex posts are automated counts of published analyst actions, not opinions. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.